logo

iStock Rating

F
Details...
Enter Symbol click to research

Allergan, Inc. (NYSE: AGN)

Sector: Medical

Current Price : $101.49

52 Week Low
$82.0752 Week High
$116.17
 

ALLERGAN I(NYSE:AGN)
Allergan, Inc. is a provider of eye care and specialty pharmaceutical products throughout the world with products in the eye care pharmaceutical, ophthalmic surgical device, over-the-counter contact lens care, movement disorder, and dermatological markets. Its worldwide consolidated revenues are principally generated by prescription and non-prescription pharmaceutical products in the areas of ophthalmology and skin care, neurotoxins, intraocular lenses and other ophthalmic surgical products, and contact lens care products.
# Employees: 10800
Address: 2525 DUPONT DRIVE,IRVINE,CA,USA
Phone: 7142464500
Fax: 714-246-6987
Website: www.allergan.com
Email:
Sector: Medical
Industry: Large Cap Pharma
Executive Officers
David E.I. Pyott (Chmn; C.E.O. & Presi)
Herbert W. Boyer (Ph.D.)
Jeffrey L. Edwards (C.F.O. & Exec V.P.)
James F. Barlow (Senior Vice President; Corporate Controller,Deborah Dunsire, M.D ,Director,)
Dividend
Ex-Dividend Date: 5/21/2013
Annual Dividend: $0.20
Current Dividend Yield: $0.20
Dividend Paid (3 months): $0.05
Indicated Dividend: $0.05
Earnings
Last Earnings Date: 3/31/2013
Next Earnings Date(Expected): 8/7/2013
Mean EPS (Next Qtr): $1.20
Mean EPS (Year): $4.75
Mean Estimate(Long Term): $13.58
P/E Ratio(Based on EPS estimate): 21.310
Number of Estimates: 18
Shares Performance
Period agn Compare to S&P
YTD 10.26 % -3.33 %
4 Weeks -0.27 % 2.23 %
12 Weeks -9.61 % -13.49 %
Shares Information
Analyst Coverage: Y
Avg Volume: 2116648
Shares Outstanding: 307M
Market Cap: $31.11B
52 Week High: $116.17
52 Week Low: $82.07
P/E Ratio: 23.740
PEG Ratio: 1.570
Split: On 6/25/2007 agn split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: -14.78 %
EPS Growth in Last Year: 13.95 %
Sales Growth in Last Quarter: -3.27 %
Sales Growth in Last Quarter: 4.86 %
Financials
Qtr Book Value: $5.61
Cash Flow/Share: $20.42
Change in Payout Ratio: -0.020
Price/Sales: 5.300
Home | Login |Research | Earnings | Scans | Stock Charts | Chart School | Glossary |Submit Article | Join Blog Network | Advertise | Subscribe to RSS

Terms of Use | Privacy Policy | Copyright 2012 all rights reserved
Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia. Advertisement partners Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.